Despite the growing market share of domestic automakers, Teslas remain among the best-selling EVs in the Asian country
auto2 hours ago
A new programme is set to make cancer immunotherapy affordable for patients in the UAE, the authorities announced on Thursday.
The UAE’s Ministry of Health and Prevention (Mohap) has inked a memorandum of understanding (MoU) with global pharmaceutical company MSD to develop a programme called AWN.
To be implemented in collaboration with licensed charities in the country, the AWN programme will cater to the needs of cancer patients who need to undergo immunotherapy, a type of biological therapy that helps one’s immune system fight the big C.
As part of the agreement, MSD will support patients who cannot cover the full cost of the treatment due to limited or lack of health insurance coverage. They will be provided with vials of an immunotherapeutic agent, a humanised monoclonal antibody (an antibody made by cloning a unique white blood cell) that helps fight cancer. This immunotherapy is used for the treatment of different cancers, such as classical Hodgkin lymphoma, melanoma, non-small cell lung cancer, and other types of solid tumours. The treatment is sometimes given alone or combined with other anti-cancer therapies.
Ashraf Malak, managing director of MSD, GCC, said: “In our mission to provide cancer patients more ways to treat their cancer and enable a better quality of life, we are proud to widen their access to cancer immunotherapy through AWN programme. The programme will help improve health equity, providing everyone an opportunity to receive the highest standard of care and attain good quality of life. By supporting programmes like these, we are working to transform the delivery of cancer care and solving social and environmental barriers to care. Our team is constantly exploring ways to help the greatest number of cancer patients across a broad range of tumour types.”
The AWN programme is being implemented in accordance with policies and recommendations of Mohap for all approved and future-approved indications of the immunotherapeutic agent in the UAE.
saman@khaleejtimes.com
Despite the growing market share of domestic automakers, Teslas remain among the best-selling EVs in the Asian country
auto2 hours ago
The entire plan will see cow-breeding and poultry projects come up near the massive wheat farm and the dairy farm will form the third phase
uae2 hours ago
Modi, 73, remains resoundingly popular after a decade in office, and he is widely expected to win a third term
asia2 hours ago
With over seven years of experience in branding and social media, and three years in motion graphics and editing, Arkan's expertise spans a wide range of creative domains
kt network2 hours ago
Names of leading brands in various sectors revealed in a new report by Brand Finance
uae2 hours ago
Four workers died when the drone struck a condensate storage tank at Khor Mor Complex, Dana Gas said in a statement to the ADX
mena3 hours ago
Experience the future of comfort and convenience with innovative smart furniture, elevating your lifestyle through seamless integration of technology and design
business technology review3 hours ago
The device is equipped solely with an AI-powered personal assistant tasked with carrying out a multitude of practical tasks
business technology review3 hours ago